At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
FOXO FOXO Technologies
Not Yet Opened 11-25 16:00:00 EST
0.3859
-0.1524
-28.31%
盘后0.4198
+0.0339+8.78%
19:59 EST
High0.5216
Low0.3800
Vol3.76M
Open0.5216
D1 Closing0.5383
Amplitude26.31%
Mkt Cap6.74M
Tradable Cap5.94M
Total Shares17.48M
T/O1.64M
T/O Rate24.42%
Tradable Shares15.38M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
FOXO Technologies Plans Special Shareholder Meeting
FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.